BDBM50334017 2-methyl-4-(3-(4-(3-(trifluoromethyl)phenyl)-1H-imidazol-2-yl)benzyl)morpholine::CHEMBL1644677

SMILES CC1CN(Cc2cccc(c2)-c2nc(c[nH]2)-c2cccc(c2)C(F)(F)F)CCO1

InChI Key InChIKey=KTXPJZIHPQLTIA-UHFFFAOYSA-N

Data  2 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 50334017   

TargetCannabinoid receptor 2(Human)
Merck Research Laboratory

Curated by ChEMBL
LigandPNGBDBM50334017(2-methyl-4-(3-(4-(3-(trifluoromethyl)phenyl)-1H-im...)
Affinity DataEC50:  25nMAssay Description:Agonist activity at human cloned CB2 receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP accumulationMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/22/2011
Entry Details Article
PubMed
TargetCannabinoid receptor 1(Human)
Merck Research Laboratory

Curated by ChEMBL
LigandPNGBDBM50334017(2-methyl-4-(3-(4-(3-(trifluoromethyl)phenyl)-1H-im...)
Affinity DataEC50: >1.00E+4nMAssay Description:Agonist activity at human cloned CB1 receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP accumulationMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/22/2011
Entry Details Article
PubMed